SCHEMBL3772575

SCHEMBL3772575

COC(=O)C1C(CN2C(=O)c3cc(Cl)c(Cl)cc3C2=O)C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CA1 P00915 3/20 0.32
CA9 Q16790 3/20 0.32
CA12 O43570 2/20 0.32
CA2 P00918 2/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
AADAT Q8N5Z0 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773345 0.85 CA9 (0.36) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL3772372 0.84 HSD17B10 (0.44) KMT2AALDH1A1KDM4EMAPTHPGD
SCHEMBL3777695 0.80 ALDH1A1 (0.49) TNFMEN1KMT2AALDH1A1KDM4E
SCHEMBL3781282 0.76 POLA1 (0.32)
SCHEMBL3770319 0.76 KDM4E (0.33) KDM4ELMNA
SCHEMBL3777323 0.75 HSD17B10 (0.39) KMT2AALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL3771889 0.75 BRD4 (0.35) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL3772460 0.73 RAB9A (0.41) ALDH1A1KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL3781377 0.72 HSD17B10 (0.43) KMT2AALDH1A1KDM4EMAPTHPGD
SCHEMBL3770019 0.69 HSD17B10 (0.43) KMT2AALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324305-A1 PRODUCTION METHOD OF POLYCYCLIC LACTAMS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-20090118519-A1 Production Method of Polycyclic Lactams SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-07 US disclosed
EP-2014647-A1 PROCESS FOR PRODUCING POLYCYCLIC LACTAM Sumitomo Chemical Company, Limited (JP) 2009-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118519-A1 Production Method of Polycyclic Lactams MRPL21, COASY, ASNS TNF 1898/4885MEN1 495/4885KMT2A 1271/4885
US-20100324305-A1 PRODUCTION METHOD OF POLYCYCLIC LACTAMS COASY, MRPL21, ASNS TNF 1994/4885MEN1 393/4885KMT2A 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.